C. Atkinson-clement, A. Letanneux, G. Baille, M. Cuartero, L. Veron-delor et al., Psychosocial Impact of Dysarthria: The Patient-Reported Outcome as Part of the Clinical Management, Neurodegenerative Diseases, pp.1-10, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02285034

N. Audibert and C. Fougeron, Distorsions de l'espace vocalique : Quelles mesures ? Application à la dysarthrie, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02436294

L. Brabenec, J. Mekyska, Z. Galaz, and I. Rektorova, Speech disorders in Parkinson's disease: Early diagnostics and effects of medication and brain stimulation, Journal of Neural Transmission, vol.124, issue.3, pp.303-334, 2017.

M. P. Cannito, D. M. Suiter, D. Beverly, L. Chorna, T. Wolf et al., , 2012.

, Sentence Intelligibility Before and After Voice Treatment in Speakers with Idiopathic Parkinson's Disease, Journal of Voice, vol.26, issue.2, pp.214-219

G. Degroote, J. Simon, S. Borel, and L. Crevier-buchman, The French version of Speech Handicap Index: Validation and comparison with the Voice Handicap Index, Folia Phoniatrica et Logopaedica, pp.20-25, 2012.
URL : https://hal.archives-ouvertes.fr/halshs-00683745

A. E. El-sharkawi, L. O. Ramig, J. A. Logemann, B. R. Pauloski, A. Rademaker et al., Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): A pilot study, Neurosurgery & Psychiatry, vol.72, issue.1, pp.31-36, 2002.

E. Ferragne, S. Flavier, and C. Fressard, ROCme! : Logiciel pour l'enregistrement et la gestion de corpus oraux, pp.19-20, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01240250

A. Ghio, D. Robert, C. Grigoli, M. Mas, C. De-looze et al., , 2014.

L. , Contraste entre les effets respectifs de l'hypodopaminergie due à la maladie de Parkinson et de l'apport thérapeutique par L-Dopa, Revue de Laryngologie Otologie Rhinologie, vol.135, issue.2, pp.63-70

C. P. Tomlinson, C. L. Deane, K. H. Brady, M. C. Smith, C. H. Sackley et al., Comparison of speech and language therapy techniques for speech problems in Parkinson's disease, Cochrane Database of Systematic Reviews, 2012.

R. J. Holmes, J. M. Oates, D. J. Phyland, and A. J. Hughes, Voice characteristics in the progression of Parkinson's disease, International Journal of Language & Communication Disorders, vol.35, issue.3, pp.407-418, 2000.

-. , F. J. Gamboa, J. Nieto, A. Guerrero, J. Orti-pareja et al., Acoustic voice analysis in untreated patients with Parkinson's disease, La maladie de Parkinson. Inserm -La science pour la santé, vol.3, pp.111-116, 1997.

M. Liotti, L. O. Ramig, D. Vogel, P. New, C. I. Cook et al., Hypophonia in Parkinson's disease: Neural correlates of voice treatment revealed by PET, Neurology, vol.60, issue.3, pp.432-440, 2003.

L. Liu, M. Jian, and W. Gu, Prosodic Characteristics of Mandarin Declarative and Interrogative Utterances in Parkinson's Disease. Interspeech, pp.3870-3874, 2019.

S. Narayana, P. T. Fox, W. Zhang, C. Franklin, D. A. Robin et al., Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis, Human Brain Mapping, vol.31, issue.2, pp.222-236, 2010.

L. O. Ramig, S. Countryman, L. Thompson, and Y. Horii, Comparison of two forms of intensive speech treatment for Parkinson Disease, Journal of Speech, Language, and Hearing Research, vol.38, issue.6, pp.1232-1251, 1995.

L. O. Ramig, S. Sapir, C. Fox, and S. Countryman, Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age-matched controls, Movement Disorders, vol.16, issue.1, pp.79-83, 2001.

L. O. Ramig, A. Halpern, J. Spielman, C. Fox, and K. Freeman, Speech treatment in Parkinson's disease: Randomized controlled trial (RCT), Movement Disorders, vol.33, issue.11, pp.1777-1791, 2018.

D. Robert and M. Spezza, La dysphonie parkinsonienne, Les troubles de la parole et de la déglutition dans la maladie de Parkinson, pp.131-143, 2005.

S. Sapir, J. L. Spielman, L. O. Ramig, B. H. Story, and C. Fox, Effects of Intensive Voice Treatment (the Lee Silverman Voice Treatment [LSVT]) on Vowel Articulation in Dysarthric Individuals with Idiopathic Parkinson Disease: Acoustic and Perceptual Findings, Journal of Speech, Language, and Hearing Research, vol.50, issue.4, pp.899-912, 2007.

J. L. Spielman, J. C. Borod, and L. O. Ramig, The Effects of Intensive Voice Treatment on Facial Expressiveness in Parkinson Disease, Cognitive and Behavioral Neurology, vol.16, issue.3, pp.177-188, 2003.

S. Wight and N. Miller, Lee Silverman Voice Treatment for people with Parkinson's: Audit of outcomes in a routine clinic, International Journal of Language & Communication Disorders, vol.50, issue.2, pp.215-225, 2015.

A. Yücetürk, H. Yilmaz, M. E?rilmez, and S. Karaca, Voice analysis and videolaryngostroboscopy in patients with Parkinson's disease, European Archives of Oto-Rhino-Laryngology, vol.259, issue.6, pp.290-293, 2002.